This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Pharmacokinetics

Authoring team

  • plasma concentration peaks within 2 hours after oral administration

  • half-life is approximately 13 hours

  • absorbed drug mainly protein bound (at least 90%)

  • reboxetine is mainly metabolised by the liver

  • there is evidence that elimination is slowed and systemic exposure increased, in patients with hepatic and renal impairment and in elderly patients

Reference:

  • Drug and Therapeutics Bulletin (1998), 36 (11), 82-4.

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.